share_log

基石藥業-B:自願公告 - 基石藥業宣佈擇捷美(舒格利單抗注射液)一線治療食管鱗癌的新適應症在中國獲批

CSTONE PHARMA-B: VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES NMPA APPROVAL OF SUGEMALIMAB AS FIRST-LINE TREATMENT FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA

香港交易所 ·  Dec 7, 2023 23:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more